Abstract
Purpose
Increasingly, women are choosing immediate breast reconstruction (IBR) following mastectomy. Reports have indicated IBR may compromise post-mastectomy radiotherapy (PMRT). We investigated the impact of IBR on timing of PMRT, target coverage, and doses to organs at risk in a modern radiotherapy practice using advanced planning techniques.
Methods
Between 2013 and 2015, PMRT was delivered to 116 patients (66 mastectomy alone, 50 IBR). PMRT was delivered with a median dose of 50 Gy in 25 fractions. Left-sided patients were treated in breath-hold under image guidance. Differences in dosimetric parameters and time to the initiation of PMRT were assessed between patients with and without reconstruction.
Results
Reconstructed patients were younger and had lower clinical stage disease. Reconstruction did not significantly increase the mean time to PMRT initiation (51 days reconstructed vs. 45 days non-reconstructed, p = 0.14) or the number of patients who initiated PMRT within 12 weeks of the last therapeutic intervention (48/50 [96.0] vs. 61/66 [92.4%], p = 0.41). There was no significant difference in the percentage of patients in whom the internal mammary lymph nodes (IMNs) were targeted (72 vs. 80%, p = 0.29) or in IMN target coverage (mean IMN V40.5 Gy 92.6 vs. 94.1%, p = 0.62). Reconstruction did not significantly affect the mean ipsilateral lung V20 (25.4 vs. 26.4%, p = 0.37) or the mean heart dose (2.2 vs. 2.1 Gy, p = 0.63).
Conclusions
In a specialized breast multidisciplinary practice, immediate breast reconstruction did not significantly delay PMRT, compromise target coverage, or increase dose to organs at risk.
Abbreviations
- IBR:
-
Immediate breast reconstruction
- PMRT:
-
Post-mastectomy radiotherapy
- IMNs:
-
Internal mammary lymph nodes
- CTV:
-
Clinical target volume
- RTOG:
-
Radiation Therapy Oncology Group
- DVH:
-
Dose-volume histogram
- PTV:
-
Planning target volume
- ER:
-
Estrogen receptor
- NCIC:
-
National Cancer Institute of Canada
- EORTC:
-
European Organization for Research and Treatment of Cancer
- DBCG:
-
Danish Breast Cancer Cooperative Group
- NSABP:
-
National Surgical Adjuvant Breast and Bowel Project
References
Budach W et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer—a meta-analysis of randomized trials- an update. Radiat Oncol 10:258
McGale P et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127–2135
Overgaard M et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–955
Overgaard M et al (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353(9165):1641–1648
Ragaz J et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97(2):116–126
Jagsi R et al (2014) Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol 32(9):919–926
Bezuhly M et al (2015) Timing of postmastectomy reconstruction does not impair breast cancer-specific survival: a population-based study. Clin Breast Cancer 15(6):519–526
Ho A et al (2012) Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation. Cancer 118(9):2552–2559
Hoskin TL et al (2015) Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery 159(4):1199–1209
Taghizadeh R et al (2015) Does post-mastectomy radiotherapy affect the outcome and prevalence of complications in immediate DIEP breast reconstruction? A prospective cohort study. J Plast Reconstr Aesthet Surg 68(10):1379–1385
Yang X, Zhu C, Gu Y (2015) The prognosis of breast cancer patients after mastectomy and immediate breast reconstruction: a meta-analysis. PLoS ONE 10(5):e0125655
Elder EE et al (2005) Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast 14(3):201–208
Pinell-White XA et al (2015) Patient-reported quality of life after breast reconstruction: a one-year longitudinal study using the WHO-QOL survey. Ann Plast Surg 75(2):144–148
Teo I et al (2015) Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction. Psychooncology. doi:10.1002/pon.3952
Froud PJ et al (2000) Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46(2):363–372
Huang J et al (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21(3):555–563
Institute NC NSABP-B51: Standard or comprehensive radiation therapy in treating patients with early-stage breast cancer previously treated with chemotherapy and surgery
Institute NC Alliance 011202: Comparison of axillary lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy
Jagsi R et al (2016) Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis. Ann Surg 263(2):219–227
Wright JL et al (2008) Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II–III breast cancer: treatment intervals and clinical outcomes. Int J Radiat Oncol Biol Phys 70(1):43–50
Momoh AO et al (2014) A systematic review of complications of implant-based breast reconstruction with pre reconstruction and post reconstruction radiotherapy. Ann Surg Oncol 21(1):118–124
Motwani SB et al (2006) The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 66(1):76–82
Darby SC et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998
Marks LB et al (2010) Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 76(3 Suppl):S70–S76
Ohri N et al (2012) Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis. Int J Radiat Oncol Biol Phys 84(2):e153–e159
Donovan E et al (2007) Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82(3):254–264
Joo JH et al (2015) Cardiac dose reduction during tangential breast irradiation using deep inspiration breath hold: a dose comparison study based on deformable image registration. Radiat Oncol 10:264
Nielsen MH et al (2013) Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 52(4):703–710
Offersen BV et al (2016) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol 118(1):205–208
Poortmans PM et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327
Recht A et al (2016) Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Pract Radiat Oncol 6(6):e219–e234
Thorsen LB et al (2016) DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol 34(4):314–320
Vikstrom J et al (2011) Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol 50(1):42–50
Whelan TJ et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316
White JTA, Arthur D, Buchholaz T, MacDonald S, Marks L, Pierce L, Recht A, Rabinovitch R, Taghian A, Vicini F, Woodward W, Allen XL (2016) Radiation Therapy oncology group breast cancer contouring Atlas. Available from https://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx
Remouchamps VM et al (2003) Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55(2):392–406
Brown LC et al (2015) Delineation of supraclavicular target volumes in breast cancer radiation therapy. Int J Radiat Oncol Biol Phys 92(3):642–649
Dijkema IM et al (2004) Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 71(3):287–295
Ho AY et al (2014) Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Med Dosim 39(1):18–22
Jethwa KR et al (2017) Delineation of internal mammary nodal target volumes in breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 97(4):762–769
Taylor CW et al (2015) Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003–2013. Int J Radiat Oncol Biol Phys 93(4):845–853
Lind PA et al (2006) ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 64(3):765–770
Mutter RW et al (2016) Initial clinical experience of postmastectomy intensity modulated proton therapy in patients with breast expanders with metallic ports. Pract Radiat Oncol. doi:10.1016/j.prro.2016.12.002
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Krishan R. Jethwa and Mohamed M. Kahila have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jethwa, K.R., Kahila, M.M., Whitaker, T.J. et al. Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT). Breast Cancer Res Treat 164, 237–244 (2017). https://doi.org/10.1007/s10549-017-4241-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-017-4241-5